Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

747 to 771 of 922 results

Japan's Fuji Pharma to buy Thai contract manufacturer for $54 million

07-08-2012

Japanese drugmaker Fuji Pharma says it has entered into an agreement with Switzerland's DKSH to acquire…

Asia-PacificFuji PharmaMergers & AcquisitionsOLICPharmaceuticalProduction

OPKO buys Farmadiet to gain presence in Europe

05-08-2012

Making its third acquisition this year, USA-based OPKO Health (NYSE: OPK) said on Friday that it has…

FarmadietMergers & AcquisitionsOPKO HealthPharmaceutical

Recordati acquires Poland's Farma-Projekt

03-08-2012

Italian drugmaker Recordati (RC: MI) said yesterday that it has signed an agreement to acquire 100% of…

Farma-ProjektGenericsMergers & AcquisitionsPharmaceuticalRecordati

Alliance Pharma acquires AstraZeneca antimalarial brands

02-08-2012

UK-based specialty drug firm Alliance Pharma (AIM: APH) has acquired the antimalarial brands Paludrine,…

Alliance PharmaAstraZenecaMergers & Acquisitions

US FDA clears Amarin's Vascepa, a competitor for Lovaza

30-07-2012

The US Food and Drug Administration has approved biotech firm Amarin's (Nasdaq: AMRN) Vascepa (icosapent…

AmarinBiotechnologyCardio-vascularGlaxoSmithKlineLovazaMergers & AcquisitionsNorth AmericaRegulationVascepa

Fresenius Kabi to acquire Fenwal

23-07-2012

Germany-based Fresenius Kabi, a provider of infusion therapy and clinical nutrition, has reached a definitive…

FenwalFresenius KabiMergers & AcquisitionsPharmaceutical

Synergy Pharma and Callisto enter merger accord

22-07-2012

USA-based biopharma groups Synergy Pharmaceuticals (Nasdaq: SGYP) and Callisto Pharmaceuticals (OTCBB:…

BiotechnologyCallisto PharmaceuticalsMergers & AcquisitionsSynergy Pharmaceuticals

Pharmaceutical supply chain in Japan sees squeezed margins

19-07-2012

Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent…

Asia-PacificBiotechnologyFinancialMarkets & MarketingMergers & AcquisitionsPharmaceuticalPricing

SYGNIS and GENETRIX to combine subsidiary X-Pol business

19-07-2012

German biotech firms SYGNIS Pharma AG (Frankfurt: LIOK) and GENETRIX have signed a binding term sheet…

BiotechnologyGENETRIXMergers & AcquisitionsQualiphiSYGNIS Pharma

Human Genome capitulates, accepting raised offer from GlaxoSmithKline

17-07-2012

Confirming weekend rumors (The Pharma Letter July 16), UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

US FTC puts conditions on Novartis buy of Fougera

17-07-2012

The USA's Federal Trade Commission said yesterday that it will require Swiss drug major drug Novartis…

DermatologicalsFougera PharmaceuticalsGenericsMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalTolmar

TPG to acquire Par Pharma for $1.9 billion

17-07-2012

Par Pharmaceutical (NYSE: PRX), a USA-based maker of generic drugs and niche innovative proprietary pharmaceuticals,…

GenericsMergers & AcquisitionsPar PharmaceuticalTPG

CritiTech sets up JV with India's Finoso Pharma for APIs

16-07-2012

USA-based CritiTech and privately-held Indian group Finoso Pharma have formally established a joint venture…

Asia-PacificCritiTechFinoso PharmaFinotech PharmaGenericsMergers & Acquisitions

BB Biotech rejects privatization proposal by Vontobel Group

16-07-2012

Swiss biotechnology investment fund BB Biotech (SIX: BION) has confirmed that Vontobel Group has made…

BB BiotechBiotechnologyEuropeFinancialMergers & AcquisitionsVontobel

Grifols acquires 40% of Spanish biotech firm VCN Bioscience

16-07-2012

Spanish health care group Grifols (GRLS: MC), the world's third largest plasma product manufacturer,…

BiotechnologyGrifolsMergers & AcquisitionsOncologyVCN Bioscience

AstraZeneca buys Link Medicines neuroscience assets; enters Alzheimer's project

12-07-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has acquired a portfolio of neuroscience assets from…

AstraZenecaLink MedicinesMergers & AcquisitionsNeurologicalPharmaceuticalResearch

Adcock Ingram expands in Indian pharma market buying Cosme Farma brands

10-07-2012

South Africa's largest health care company Adcock Ingram (AIP: SJ) says it has reached an agreement to…

Adcock IngramCosme FarmaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Alchemia oncology demerger plans

09-07-2012

Australia-based Alchemia (ASX: ACL) says it is progressing well with preparations to demerge its oncology…

AlchemiaAudeo OncologyMergers & AcquisitionsOncologyPharmaceutical

AstraZeneca completes sale of Aptium Oncology assets

09-07-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says that it has completed the previously indicated sale…

Aptium OncologyAstraZenecaMergers & AcquisitionsOncologyPharmaceutical

Spectrum extends tender offer for Allos

09-07-2012

US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) said late Friday that it has again extended tender…

Allos TherapeuticsBiotechnologyFolotynMergers & AcquisitionsOncologySpectrum Pharmaceuticals

Bilthoven Biologicals acquired by Serum Institute of India

06-07-2012

Bilthoven Biologicals, a Dutch manufacturer of monoclonal antibodies and vaccines, said this week that…

Bilthoven BiologicalsBiotechnologyMergers & AcquisitionsPharmaceuticalSerum Institute of IndiaVaccines

747 to 771 of 922 results

Back to top